OnCusp Therapeutics Alternatives & Competitors
12 companies similar to OnCusp Therapeutics — We Bring Oncology Innovation to Life
Companies similar to OnCusp Therapeutics
Prelude Therapeutics
Precision Oncology, Redefined.
Wilmington, United States
Pannex Therapeutics Inc.
We are the Pannexin people.
New York, United States
NBE-Therapeutics AG
Next generation antibody drug conjugates
Basel, Switzerland
Rexahn Pharmaceuticals
TARGETING DIFFICULT TO TREAT CANCERS
Rockville, United States
Rival Readout
Competing with OnCusp Therapeutics? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
KeifeRx
KeifeRx is a biopharmaceutical company finding disease-modifying treatments for neurodegen...
Mclean, United States
Arcus Biosciences
Biopharmaceutical company developing differentiated molecules and combination therapies fo...
Hayward, United States
Sumitomo Pharma Oncology
is part of Sumitomo Pharma America as of July 2023
Cambridge, United States
Cure51
We want every patient to become a Cancer Survivor.
Paris, France
Avenzo Therapeutics
Developing the next generation of oncology therapies for patients
San Diego, United States
Bolt Biotherapeutics, Inc.
Plans to develop a novel format for T-cell mediated anti-tumour therapy
Redwood City, United Stat...
Kestrel Therapeutics
We aspire to invent brilliant technologies for difficult cancer targets, beginning with mu...
Watertown, United States
About OnCusp Therapeutics
OnCusp Therapeutics is a promising player in the biopharmaceutical industry, founded in 2021 with headquarters in the United States. Their mission, elegantly encapsulated in their slogan, "We Bring Oncology Innovation to Life," reflects a dedication to evolving preclinical discoveries into validated cancer treatments....
Development of Oncology Treatments, Clinical R&D, Partnership and Collaboration, Business Development
Cancer Patients, Healthcare Providers, Pharmaceutical Companies, Research Institutions
Biopharmaceutical, Oncology, Cancer Treatments, Preclinical Innovation, Clinical Validation, Drug Development, Biotech Startups, Global Partnerships, Oncology Assets, Innovation Acceleration, Research Asset Transformation, Oncology Medication Innovation
B2B
Licensing, Performance Based, Product Sales
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around OnCusp Therapeutics: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at OnCusp Therapeutics on 9 Jun 2026. The 12 companies listed here were last checked between 12 Sep 2024 and 25 Aug 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
